Ro15-4513 is primarily researched for its potential to counteract the effects of alcohol intoxication. It acts as a partial inverse agonist at GABA_A receptors, which are the primary targets of alcohol in the brain. By modulating these receptors, it may help reduce the sedative and intoxicating effects of alcohol, making it a subject of interest in studies related to alcohol dependence and overdose treatment. Additionally, its interaction with GABA_A receptors has sparked investigations into its possible use in anxiety and memory-related disorders, though these applications remain largely experimental. Its precise therapeutic potential is still under exploration, with ongoing research focusing on its efficacy and safety profile.